Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
OMG (gene)
Introduction
Oligodendrocyte-myelin glycoprotein is a protein that in humans is encoded by the OMG gene.[1][2][3]
References
References
- ↑ Viskochil D, Cawthon R, O’Connell P, Xu GF, Stevens J, Culver M, Carey J, White R (Mar 1991). “The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene”. Mol Cell Biol. 11 (2): 906–12. PMC 359746. PMID 1899288.
- ↑ Mikol DD, Alexakos MJ, Bayley CA, Lemons RS, Le Beau MM, Stefansson K (Mar 1991). “Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein”. J Cell Biol. 111 (6 Pt 1): 2673–9. doi:10.1083/jcb.111.6.2673. PMC 2116377. PMID 2277079.
- ↑ “Entrez Gene: OMG oligodendrocyte myelin glycoprotein”.
Further reading
Further reading
- Mikol DD, Gulcher JR, Stefansson K (1990). “The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate”. J. Cell Biol. 110 (2): 471–9. doi:10.1083/jcb.110.2.471. PMC 2116011. PMID 1688857.
- Mikol DD, Stefansson K (1988). “A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes”. J. Cell Biol. 106 (4): 1273–9. doi:10.1083/jcb.106.4.1273. PMC 2115011. PMID 3283151.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Mikol DD, Rongnoparut P, Allwardt BA, et al. (1993). “The oligodendrocyte-myelin glycoprotein of mouse: primary structure and gene structure”. Genomics. 17 (3): 604–10. doi:10.1006/geno.1993.1379. PMID 8244377.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Wang KC, Koprivica V, Kim JA, et al. (2002). “Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth”. Nature. 417 (6892): 941–4. doi:10.1038/nature00867. PMID 12068310.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Vourc’h P, Moreau T, Arbion F, et al. (2003). “Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor”. J. Neurochem. 85 (4): 889–97. doi:10.1046/j.1471-4159.2003.01764.x. PMID 12716421.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Venturin M, Moncini S, Villa V, et al. (2007). “Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation” (PDF). Neurogenetics. 7 (1): 59–66. doi:10.1007/s10048-005-0026-9. PMID 16425041.
- Douglas J, Cilliers D, Coleman K, et al. (2007). “Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth”. Nat. Genet. 39 (8): 963–5. doi:10.1038/ng2083. PMID 17632510.